Biochemical, pathological, and clinical response to transplantation of normal bone marrow cells into acid sphingomyelinase-deficient mice

Transplantation

Volumn 65, Issue 7, 1998, Pages 884-892

  Miranda, Silvia R P ^a   Erlich, Shai ^a   Friedrich Jr , Victor L ^a   Haskins, Mark E ^b   Gatt, Shimon ^c   Schuchman, Edward H ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c HEBREW UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

SPHINGOMYELIN PHOSPHODIESTERASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; CEREBELLUM; ENZYME RELEASE; KNOCKOUT MOUSE; LYSOSOME; MOUSE; NIEMANN PICK DISEASE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANIMALS, NEWBORN; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CELL DIVISION; DISEASE MODELS, ANIMAL; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NIEMANN-PICK DISEASES; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOMYELINS; WHOLE-BODY IRRADIATION;

EID: 0032522712     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199804150-00005     Document Type: Article

References (28)

1. Schuchman EH, Desnick RJ. Niemann-Pick disease types A and B: acid sphingomyelinase deficiences. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular basis of inherited disease. New York: McGraw-Hill, 1995: 2601.
2. Daloze P, Delvin EE, Glorieux FH, Corman JL, Bettez P, Toussi T. Replacement therapy for inherited enzyme deficiency: liver orthotopic transplantation in Niemann-Pick disease type A. Am J Med Genet 1977; 1: 229.
3. Gartner JC, Bergman I, Malatack JJ, et al. Progression of neurovisceral storage disease with supranuclear ophthalmoplegia following orthotopicliver transplantation. Pediatrics 1986; 77: 104.
4. Scaggiante B, Pineschi A, Sustersich M, Andolina M, Agosti E, Romeo O. Successful therapy of Niemann-Pick disease by implantation of human amniotic membrane. Transplantation 1987; 44: 59.
5. Vellodi A, Hobbs JR, O'Donnell NM, Coulter BS, Hugh-Jones K. Treatment of Niemann-Pick disease type B by allogeneic bone marrow transplantation. Br Med J Clin Res Ed 1987; 295: 1375.
6. Krivit W, Whitley CB, Chang P-N, et al. Lysosomal storage diseases treated by bone marrow transplantation: review of 21 patients. In: Leonard Johnson F, Pochedly C, eds. Bone marrow transplantation in children. New York: Raven Press, 1990: 261.
7. Bayeuer E, Kamani N, Ferreira P, et al. Bone marrow transplantation for Niemann-Pick type IA disease. J Inherit Metab Dis 1992; 15: 919.
8. Yeyati PL, Agmon V, Fillat C, et al. Fluorescent-based selection of retrovirally transduced cells in the absence of a marker gene: direct selection of transduced type B Niemann-Pick disease cells and evidence for bystander correction. Hum Gene Ther 1995; 6: 975.
9. Hoogerbrugge PM, Suzuki K, Poorthuis BJHM, Kobayashi T, Wagemaker G, van Bekkum DW. Donor-derived cells in the central nervous system of twitcher mice after bone marrow transplantation. Science 1988; 239: 1035.
10. Sands MS, Barker JE, Vogler C, et al. Treatment of murine mucopolysaccharidosis type VII by syngeneic bone marrow transplantation in neonates. Lab Invest 1993; 68: 676.
11. Walkey SU, Thrall MA, Dobrenis K, et al. Bone marrow transplantation corrects the enzyme defect in neurons of the central nervous system in a lysosomal storage disease. Proc Natl Acad Sci USA 1994; 91: 2970.
12. Horinouchi K, Erlich S, Perl DP, et al. Acid sphingomyelmase deficient mice: a model of types A and B Niemann-Pick disease. Nat Genet 1995; 10: 288.
13. Otterbach B, Stoffel W. Acid sphingomyelinase-deficient mice mimic the neurovisceral form of human lysosomal storage disease (Niemann-Pick disease). Cell 1995; 81: 1053.
14. Miranda SRP, Erlich S, Visser JWM, et al. Bone marrow transplantation in acid sphingomyelinase-deficient mice: engraftment and cell migration into the brain as a function of radiation, age, and phenotype. Blood 1997; 90: 444.
15. Dinur T, Schuchman EH, Fibach E, et al. Toward gene therapy for Niemann-Pick disease (NPD): separation of retrovirally corrected and non-corrected NPD fibroblasts using a novel fluorescent sphingomyelin. Hum Gene Ther 1992; 3: 633.
16. Stein S, Bohlen P, Stone J, Dairman W, Udenfriend S. Amino acid analysis with fluorescamine at the picomole level. Arch Biochem Biophys 1973; 155: 202.
17. 2+-stimulated sphyngomyelinase is secreted by many cell types and is a product of the acid sphingomyelinase gene. J Biol Chem 1996; 271: 18431.
18. Rousseau A, Livni N, Gatt S. Utilization of membranous lipid substrates by membranous enzymes: activation of the latent sphingomyelinase of hen erythrocyte membrane. Arch Biochem Biophys 1986; 244: 838.
19. Goslin K, Banker G. Rat hippocampal neurons in low density culture. In: Banker G, Goslin K, eds. Culturing nerve cells. Cambridge: MIT Press, 1991: 251.
20. Benson DL, Watkins FH, Steward O, Banker G. Characterization of GABAergic neurons in hippocampal cell cultures. J Neurocytol 1994; 23: 279.
21. Higashi Y, Murayama S, Pentchev PG, Suzuki K. Cerebellar degeneration in the Niemann-Pick type C mouse. Acta Neuropathol 1993; 85: 175.
22. Triarhou LC, Zhang W, Lee WH. Graft-induced restoration of function in hereditary cerebellar ataxia. Neuroreport 1995; 6: 1827.
23. Tu PH, Robinson KA, de Snoo F, et al. Selective degeneration of Purkinje cells with Lewy body-like inclusions in aged NF-HLACZ transgenic mice. J Neurosci 1997; 17: 1064.
24. Khan MA. Histochemical and ultrastructural investigation of heterogenous Purkinje neurons in mammalian cerebellum. Cell Mol Biol Res 1993; 39: 789.
25. Doughty ML, Patterson L, Caddy KW. Cerebellar Purkinje cells from the lurcher mutant and wild-type mouse grown in vitro: a light and electron microscope study. J Comp Neurol 1995; 357: 161.
26. Dick DJ, Boakes RJ, Candy JM, Harris JB, Cullen MJ. Cerebellar structure and function in the murine mutant "jolting." J Neurol Sci 1986; 76: 255.
27. Kuemmel TA, Schroeder R, Stoffel W. Light and electron microscopic analysis of the central and peripheral nervous systems of acid sphingomyelinase-deficient mice resulting from gene targeting. J Neuropathol Exp Neurol 1997; 56: 171.
28. Suchi M, Dinur T, Desnick RJ, et al. Retroviral-mediated transfer of the human acid sphingomyelinase cDNA: correction of the metabolic defect in cultured Niemann-Pick disease cells. Proc Natl Acad Sci USA 1992; 91: 4332.